ADM and pneumonia: Recently new attention is being focused on adreno-medullin and specifically on its more stable midregional fragment pro-adrenomedullin (MR-pro-ADM) [16], which has demonstrated to be the most reliable biomarker available in mortality and prognosis prediction for pneumonia (and many other diseases) [17–21].